» Authors » Stijn van der Veen

Stijn van der Veen

Explore the profile of Stijn van der Veen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 63
Citations 2029
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen S, Zhu J, Hua C, Feng C, Wu X, Zhou C, et al.
Virol Sin . 2024 Oct; 39(6):860-874. PMID: 39426602
Genital herpes (GH) is a common sexually transmitted disease, which is primarily caused by herpes simplex virus type 2 (HSV-2), and continues to be a global health concern. Although our...
2.
Yang F, Sun X, Fu Y, Zhao F, Lin X, Chen Y, et al.
J Antimicrob Chemother . 2024 Aug; 79(11):2854-2857. PMID: 39186249
Objectives: Neisseria gonorrhoeae strains associated with the high-level ceftriaxone-resistant FC428 clone or containing its main resistance determinant, penA allele 60.001, have shown global transmission. In Hangzhou, China, 10% of the...
3.
Gao S, van der Veen S
Autophagy . 2024 May; 20(9):2114-2116. PMID: 38762749
Outer membrane vesicles (OMVs) are nanometer-sized membrane blebs secreted by all Gram-negative bacteria to facilitate bacterial communication and modulate the external environment, including in the context of host-microbe interactions. releases...
4.
Gao S, Gao L, Yuan D, Lin X, van der Veen S
Nat Commun . 2024 Feb; 15(1):1669. PMID: 38396029
The bacterial pathogen Neisseria gonorrhoeae is able to invade epithelial cells and survive intracellularly. During this process, it secretes outer membrane vesicles (OMVs), however, the mechanistic details for interactions between...
5.
Gu Y, Song S, Zhu Q, Jiao R, Lin X, Yang F, et al.
Microbiol Spectr . 2023 Nov; 11(6):e0244923. PMID: 37982635
Ceftriaxone-based antimicrobial therapies for gonorrhea are threatened by waning ceftriaxone susceptibility levels and the global dissemination of the high-level ceftriaxone-resistant gonococcal FC428 clone. Combination therapy can be an effective strategy...
6.
Gao S, Yuan D, Gao L, Yang F, Lin X, van der Veen S
J Infect Dis . 2023 Nov; 228(12):1776-1788. PMID: 37926090
Neisseria gonorrhoeae establishes tight interactions with mucosal epithelia through activity of its type IV pilus, while pilus retraction forces activate autophagic responses toward invading gonococci. Here we studied pilus-independent epithelial...
7.
Song S, Wang S, Jiang X, Yang F, Gao S, Lin X, et al.
Emerg Microbes Infect . 2023 Aug; 12(2):2249124. PMID: 37584947
Global dissemination of high-level ceftriaxone-resistant strains associated with the FC428 clone poses a threat to the efficacy ceftriaxone-based therapies. Vaccination is the best strategy to contain multidrug-resistant infections. In this...
8.
Hua C, Liang Q, Chen S, Zhu J, Tang Y, Chen X, et al.
Stem Cell Res Ther . 2023 May; 14(1):147. PMID: 37248497
Background: Atopic dermatitis (AD) is one of the most common immune and inflammatory skin disorders, leading to insufferable itching and skin abnormalities that seriously affect life quality of patients. There...
9.
Al Rudaisat M, Chen X, Chen S, Amanullah M, Wang X, Liang Q, et al.
Life Sci . 2023 May; 326:121788. PMID: 37230377
Aim: Psoriasis is one of the most common dermatological disorders, characterized by increased epidermal hyperplasia and immune cell infiltration. Psychological stress has been reported to contribute to the severity, aggravation,...
10.
Yang F, Liu J, Gu Y, Jiao R, Yan J, Gao S, et al.
Microbiol Spectr . 2022 Nov; 10(6):e0395222. PMID: 36350125
Alternative antimicrobial therapies are urgently required for the multidrug-resistant bacterial pathogen Neisseria gonorrhoeae, for which currently ceftriaxone is the only remaining recommended first-line therapy. Repurposing of drugs that are approved...